Mesa Laboratories Inc: (NASD: MLAB)

$53.24

0.06 (0.11%)

Volume 12,373

Jun 18 04:00 PM ET

Zacks Rank: NA

 
 
 
 
 

Balance Sheet

Get Balance Sheet for:

Annual Balance Sheet

Fiscal Year End for MESA LABS INC falls in the month of March.

All items in Millions except Per Share data.

03/31/13 03/31/12 03/31/11 03/31/10 03/31/09
Assets          
Cash & Equivalents 4 7 4 10 9
Receivables 8 6 7 4 4
Notes Receivable 0 0 0 0 0
Inventories 6 4 6 5 4
Other Current Assets 1 2 2 1 1
Total Current Assets 19 19 17 20 19
Net Property & Equipment 7 7 7 4 4
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 39 24 26 9 7
Deposits & Other Assets 0 0 0 0 0
Total Assets 66 51 51 34 30
Liabilities & Shareholders Equity 03/31/13 03/31/12 03/31/11 03/31/10 03/31/09
Notes Payable 0 0 5 0 0
Accounts Payable 1 1 1 0 0
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 3 3 3 1 1
Income Taxes Payable 1 1 1 0 0
Other Current Liabilities 0 0 1 0 0
Total Current Liabilities 5 4 10 2 1
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2 3 3 0 1
Convertible Debt 0 0 0 0 0
Long-Term Debt 4 0 0 0 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2 0 2 0 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 13 7 15 2 2
Shareholders Equity 03/31/13 03/31/12 03/31/11 03/31/10 03/31/09
Preferred Stock 0 0 0 0 0
Common Stock (Par) 11 7 6 5 5
Capital Surplus 0 0 0 0 0
Retained Earnings 42 38 31 26 23
Other Equity -0 -0 -0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 53 44 36 31 28
Total Liabilities & Shareholder's Equity 66 51 51 34 30
Total Common Equity 53 44 36 31 28
Shares Outstanding 3.30 3.20 3.20 3.20 3.10
Book Value Per Share 15.98 13.72 11.38 9.75 8.90

Quarterly Balance Sheet

Fiscal Year End for MESA LABS INC falls in the month of March.

All items in Millions except Per Share data.

03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Assets          
Cash & Equivalents 4 3 3 5 7
Receivables 8 8 7 7 6
Notes Receivable 0 0 0 0 0
Inventories 6 5 6 6 4
Other Current Assets 1 1 1 1 2
Total Current Assets 19 17 17 18 19
Net Property & Equipment 7 7 7 7 7
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 39 40 40 41 24
Deposits & Other Assets 0 0 0 0 0
Total Assets 66 64 64 67 51
Liabilities & Shareholders Equity 03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Notes Payable 0 0 0 0 0
Accounts Payable 1 1 1 1 1
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 3 3 2 2 3
Income Taxes Payable 1 0 1 2 1
Other Current Liabilities 0 0 0 0 0
Total Current Liabilities 5 4 3 5 4
Mortgages 0 0 0 0 0
Deferred Taxes/Income 2 3 3 3 3
Convertible Debt 0 0 0 0 0
Long-Term Debt 4 5 8 11 0
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 2 2 2 2 0
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 13 14 16 21 7
Shareholders Equity 03/31/13 12/31/12 09/30/12 06/30/12 03/31/12
Preferred Stock 0 0 0 0 0
Common Stock (Par) 11 8 7 7 7
Capital Surplus 0 0 0 0 0
Retained Earnings 42 43 41 39 38
Other Equity -0 -0 -0 -0 -0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 53 50 48 46 44
Total Liabilities & Shareholder's Equity 66 64 64 67 51
Total Common Equity 53 50 48 46 44
Shares Outstanding 3.30 3.30 3.30 3.20 3.20
Book Value Per Share 15.98 15.18 14.66 14.37 13.72

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.